Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BJDX
- Price
- 2.34
- Stock movement down
- -0.30 (-11.36%)
- Company name
- Bluejay Diagnostics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 1.29M
- Ent value
- -3.27M
- Price/Sales
- 0.89
- Price/Book
- 0.18
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -55.75%
- 3 year return
- -76.02%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-14
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
BJDX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.89 |
| Price to Book | 0.18 |
| EV to Sales | -2.26 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 552.85K |
| EPS (TTM) | -0.90 |
| FCF per share (TTM) | -0.97 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.45M |
| Gross profit (TTM) | 1.28M |
| Operating income (TTM) | -8.07M |
| Net income (TTM) | -8.59M |
| EPS (TTM) | -0.90 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 88.66% |
| Operating margin (TTM) | -556.95% |
| Profit margin (TTM) | -592.61% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 5.76M |
| Net receivables | 0.00 |
| Total current assets | 6.57M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 8.35M |
| Accounts payable | 316.65K |
| Short/Current long term debt | 241.65K |
| Total current liabilities | 1.05M |
| Total liabilities | 1.19M |
| Shareholder's equity | 7.16M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -8.86M |
| Capital expenditures (TTM) | 393.55K |
| Free cash flow (TTM) | -9.25M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -119.88% |
| Return on Assets | -102.81% |
| Return on Invested Capital | -118.04% |
| Cash Return on Invested Capital | -127.16% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.55 |
| Daily high | 2.62 |
| Daily low | 2.28 |
| Daily Volume | 241K |
| All-time high | 787.20 |
| 1y analyst estimate | 256.00 |
| Beta | 0.73 |
| EPS (TTM) | -0.90 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BJDX | S&P500 | |
| Current price drop from All-time high | -99.70% | -12.04% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 15 Nov 2024 | 9 Mar 2009 |
| Avg drop from high | -88.96% | -11.07% |
| Avg time to new high | 859 days | 12 days |
| Max time to new high | 858 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
1.29M
Marketcap category
Small-cap
Description
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Employees
10
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page